Forgot your password?
New User?
Remember me
banner banner

You are here:Home » Antibodies » Antibodies-Smad Proteins » Anti -Smad2 (MADH2, Small Mothers Against Decapentaplegic Deleted in Pancreatic Carcinoma)

Anti -Smad2 (MADH2, Small Mothers Against Decapentaplegic Deleted in Pancreatic Carcinoma)


  For pricing information, USA customers sign in.
  Outside USA? Please contact your distributor for pricing.


Clone Host Grade Applications
Polyclonal Goat Affinity Purified B
SMAD2 protein (also known as MADH2) is a transcriptional modulator activated by TGF beta. It is found at high levels in skeletal muscle, heart and placenta. SMAD2 exists in isoforms, a predominant long form and a short form missing the 30 amino acid exon 3. The short form shows DNA binding and higher transcriptional activation activity. SMAD2 may act as a tumor suppressor in colorectal carcinoma.
Catalog #S1014-52
ApplicationsSuitable for use in Western Blot. Other applications have not been tested.
Recommended DilutionWestern Blot: 1:100-1:250. Detects bands of ~45kD and 50kD in HeLa cell lysates. A minimum incubation time of 1 hour is recommended.
Optimal working dilutions to be determined by researcher.
Storage and StabilityMay be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Clone TypePolyclonal
FormSupplied as a liquid in TBS, pH 7.3, 0.02% sodium azide, 0.5% BSA, before the addition of glycerol to 40%.
PurityPurified by immunoaffinity chromatography.
ImmunogenSynthetic peptide (SEIWGLSTPNTID) derived from SMAD2 protein sequence.
SpecificityRecognizes human SMAD2.
Important NoteThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.

External Links